HomeADVM • NASDAQ
add
Adverum Biotechnologies Inc
Nakaraang pagsara
$4.52
Sakop ng araw
$4.23 - $4.51
Sakop ng taon
$4.23 - $29.60
Market cap
88.83M USD
Average na Volume
218.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.00M | — |
Gastos sa pagpapatakbo | 9.78M | -29.06% |
Net na kita | -27.13M | 17.49% |
Net profit margin | -2.71K | — |
Kita sa bawat share | -1.30 | 60.61% |
EBITDA | -28.33M | 14.20% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 153.24M | 30.88% |
Kabuuang asset | 234.38M | 19.11% |
Kabuuang sagutin | 90.26M | -4.04% |
Kabuuang equity | 144.12M | — |
Natitirang share | 20.80M | — |
Presyo para makapag-book | 0.65 | — |
Return on assets | -29.93% | — |
Return on capital | -31.81% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -27.13M | 17.49% |
Cash mula sa mga operasyon | -21.12M | 11.66% |
Cash mula sa pag-invest | -13.35M | -173.34% |
Cash mula sa financing | 0.00 | 100.00% |
Net change in cash | -34.47M | -492.17% |
Malayang cash flow | -11.77M | 36.71% |
Tungkol
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Itinatag
Ene 1, 2006
Headquarters
Website
Mga Empleyado
121
